News

EULAR 2017: Romosozumab reduces the risk of clinical vertebral fractures in postmenopausal women with osteoporosis by as much as five times.

Tocilizumab may be associated with increasing LDL cholesterol in rheumatoid arthritis, but a new study shows that it is not associated with increased cardiovascular risk.

The drug helped patients achieve clinical remission, low disease activity.

The severity of long-term chronic pain that impedes daily life seems to be associated with higher mortality, researchers report.

Sjogren’s fails a clinical trial with rituximab and a cost analysis. Even with a significant discount, it’s still not cost effective.

A quick summary of the 2012 American College of Rheumatology guidelines for the management of gout.

The nuances of word choice in a doctor’s office may hold greater meaning than you think.

This study is among the first to show that aggressive treatment of early rheumatoid arthritis with biologic DMARDs benefits high-risk patients.

Tocilizumab in its subcutaneous form is the first-ever drug designated for giant cell arteritis which affects 230,000 people in the U.S

Systemic sclerosis. Its rarity could lead to delays in diagnosis which, according to a review, may not be fully understood by inexperienced physicians.

This is the first FDA-approved therapy specific to this form of vasculitis.

A Lyme arthritis diagnosis requires a two-step testing approach. False positives are complex and common.

The combination of alcohol and methotrexate is generally frowned upon, but a new study suggests alcohol in small quantities may be OK.

Chili peppers, turmeric, chocolate and red wine could possibly control immune hyperactivity in rheumatoid arthritis and lupus, a review shows.

Celecoxib is preferred over naproxen for arthritis patients at high risk for cardiovascular and gastrointestinal events, researchers report.

Early stage RA treated with tocilizumab or tocilizumab and methotrexate realized clinical benefits with no safety concerns at two years.

Mayo Clinic’s Dr. Eric Matteson and Dr. Sharon Chung of UCSF provide an update on advances in new treatments for vasculitis.

Kinesiophobia, or the fear of movement, may keep knee osteoarthritis patients from physical therapy and by consequence, recovery.

A large international study shows there is no increased risk of melanoma in rheumatoid arthritis disproving previous analyses.

Research from UNC may bring medicine closer to understanding the conundrum.

Pso and PsA are associated with higher rates of pathological fractures.

LFA-REAL offers a straight-forward evaluation for lupus-affected organ systems, a study shows.

In this case study, Dr. Litvin presents a complicated case of neuromyelitis optica (Devic’s disease), a rare inflammatory autoimmune CNS disease affecting the spinal cord and optic nerves.

A patient with uncontrolled hypertension, long-term Raynaud’s phenomenon, altered mental status, facial droop, dysarthria, diplopia and renal crisis.

Designated a breakthrough therapy for pemphigus vulgaris, rituximab has been shown to work better than prednisone alone and with fewer adverse events, researchers report in The Lancet.

Inflammatory bowel disease is associated with arthritis. Research suggests there could be a genetic component or the connection could be associated with an inflamed gut. Learn more here.

NIAID Director Anthony Fauci, MD is globally renowned for immunology research.

The first-ever treatment guidelines for systemic Sjogren’s syndrome have been issued highlighting the need to alleviate symptoms, improve quality of life and prevent further damage.

Patients sometimes insist on non-traditional therapies after a rheumatoid arthritis diagnosis. Their concerns shouldn't be ignored and instead, patients should be counseled on therapeutic options.

Patients with moderate to high total cholesterol and low-density lipoprotein levels are at increased risk for failed arthroscopic rotator cuff repair surgery, researchers reported at AAOS 2017 this week.